After a 34-year-old man experienced a life-threatening allergic reaction after stepping out of a hot shower, doctors discovered a rare and serious condition behind his collapse: The man had cold-induced urticaria and anaphylaxis.
President-elect Joe Biden has made it clear that combating America's novel coronavirus epidemic will be his top priority once he assumes office—and this week, he released more details on how he intends to do so. Daily Briefing's Ashley Fuoco Antonelli breaks down how Biden plans to address the epidemic during his first 100 days in office and beyond.
An FDA advisory panel on Thursday recommended that the agency authorize the emergency use of Pfizer's and BioNTech's coronavirus vaccine candidate, which means the inoculation's authorization may come within the next few days.
Three months ago, Advisory Board's Brandi Greenberg wrote an article called, "A vaccine approval is coming. Get ready to ask these 8 questions." Now, she's back to evaluate whether the just-authorized vaccine by Pfizer and BioNTech is truly safe and effective—and to answer a new, ninth question that could be the most important one of all.
IBM warns of cyberattacks targeting companies and government organizations in charge of Covid-19 vaccine distribution, AstraZeneca and Oxford University release data showing their vaccine candidate is moderately effective, and more.
Google on Wednesday announced the launch of its Google Health Studies app and said its first study—conducted in partnership with Harvard Medical School and Boston Children's Hospital—will look at the spread of Covid-19 and other respiratory diseases, in today's bite-sized hospital and health industry news from Massachusetts, Ohio, and Pennsylvania.